neurons.ai
ProMIS Neurosciences commends Biogen for clarifying aducanumab regulatory filing
TORONTO and CAMBRIDGE, Mass., April 22, 2020 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology …
